SE0303135D0 - Controlled food effect composition - Google Patents

Controlled food effect composition

Info

Publication number
SE0303135D0
SE0303135D0 SE0303135A SE0303135A SE0303135D0 SE 0303135 D0 SE0303135 D0 SE 0303135D0 SE 0303135 A SE0303135 A SE 0303135A SE 0303135 A SE0303135 A SE 0303135A SE 0303135 D0 SE0303135 D0 SE 0303135D0
Authority
SE
Sweden
Prior art keywords
food effect
effect composition
controlled food
pharmaceutical composition
lipid material
Prior art date
Application number
SE0303135A
Other languages
English (en)
Inventor
Peter Kaufmann
Karin Bohlinder
Goeran Nilsson
Jan Holmbaeck
Original Assignee
Lipocore Holding Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipocore Holding Ab filed Critical Lipocore Holding Ab
Priority to SE0303135A priority Critical patent/SE0303135D0/sv
Publication of SE0303135D0 publication Critical patent/SE0303135D0/sv
Priority to US10/580,786 priority patent/US20080044486A1/en
Priority to PCT/SE2004/001727 priority patent/WO2005051354A1/en
Priority to EP04800388A priority patent/EP1686958A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0303135A 2003-11-25 2003-11-25 Controlled food effect composition SE0303135D0 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE0303135A SE0303135D0 (sv) 2003-11-25 2003-11-25 Controlled food effect composition
US10/580,786 US20080044486A1 (en) 2003-11-25 2004-11-24 Controlled Food Effect Composition
PCT/SE2004/001727 WO2005051354A1 (en) 2003-11-25 2004-11-24 Controlled food effect composition
EP04800388A EP1686958A1 (en) 2003-11-25 2004-11-24 Controlled food effect composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0303135A SE0303135D0 (sv) 2003-11-25 2003-11-25 Controlled food effect composition

Publications (1)

Publication Number Publication Date
SE0303135D0 true SE0303135D0 (sv) 2003-11-25

Family

ID=29729152

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0303135A SE0303135D0 (sv) 2003-11-25 2003-11-25 Controlled food effect composition

Country Status (4)

Country Link
US (1) US20080044486A1 (sv)
EP (1) EP1686958A1 (sv)
SE (1) SE0303135D0 (sv)
WO (1) WO2005051354A1 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013096444A1 (en) * 2011-12-19 2013-06-27 Salix Pharmaceuticals, Ltd. Methods for treatment and prevention of opioid induced constipation using oral compositions of methylnaltrexone
US9078925B2 (en) * 2012-06-18 2015-07-14 Galephar Pharmaceutical Research, Inc. Pharmaceutical semi-solid composition of isotretinoin
KR101633292B1 (ko) * 2014-02-25 2016-06-24 동아에스티 주식회사 용법이 개선된 엔테카비어를 함유하는 약학적 조성물
WO2015130083A1 (ko) * 2014-02-25 2015-09-03 동아에스티 주식회사 용법이 개선된 엔테카비어를 함유하는 약학적 조성물
WO2015181802A2 (en) * 2014-05-29 2015-12-03 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition of isotretinoin
BR112017001963A2 (pt) * 2014-07-31 2017-11-21 Sun Pharmaceutical Ind Ltd composição farmacêutica oral, seu processo de preparação e método de tratamento
CA3096692A1 (en) * 2018-04-17 2019-10-24 Poviva Corp. Lipophilic active agent infused compositions with reduced food effect

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19819273A1 (de) * 1998-04-30 1999-11-11 Pharmatec International S Giul Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung
PE20001227A1 (es) * 1998-10-30 2000-11-06 Hoffmann La Roche Procesos para producir una composicion de isotretinoina
SE9804192D0 (sv) * 1998-12-03 1998-12-03 Scotia Lipidteknik Ab New formulation
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
DE60104206T2 (de) * 2000-09-22 2005-09-22 Galephar M/F Halbfeste arzneizubereitung enthaltend isotretinoin

Also Published As

Publication number Publication date
EP1686958A1 (en) 2006-08-09
WO2005051354A1 (en) 2005-06-09
US20080044486A1 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
BRPI0608297A2 (pt) composições de lipossomos
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
BRPI0520669A2 (pt) dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina
AR051397A1 (es) Composicion farmaceutica
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
CY1113462T1 (el) Μορφη δοσολογιας περιεχουσα παντοπραζολη ως δραστικο συστατικο
CY1113003T1 (el) Ευσταθη παρασκευασματα laquinimod
EA200602092A1 (ru) Способ и композиция для лечения ринита
EA200601253A1 (ru) Преимущественно линейная шипучая лекарственная форма фентанила для перорального применения и способы введения
CY1118179T1 (el) Φαρμακευτικη συνθεση
GT200500363A (es) 3-amino-pirazol [3,4b] piridinas con inhibidores de proteintirosinquinasas, su preparacion y uso como medicamento.
CY1110558T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
CY1109142T1 (el) Χαρακτηρισμος: σπειροκυκλικα παραγωγα κυκλοεξανιου
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
ATE543491T1 (de) Kombinationspräparat enthaltend ibuprofen und paracetamol
AR109263A2 (es) Composición que comprende moxidectina
CR8371A (es) Formulaciones de medicamento que contienen saborizantes con mejores propiedades farmaceuticas
CY1112637T1 (el) Παραγων για την προληψη και αγωγη των παθησεων του ηπατος περιεχοντας παραγωγο πυραζολοπυριμιδινης
SE0303135D0 (sv) Controlled food effect composition
CY1119315T1 (el) Στερεες μορφες που περιεχουν μελοξικαμη με βελτιωμενη στοματικη γευση και η διαδικασια για τηn προετοιμασια τους
BRPI0700133A (pt) composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
UY30126A1 (es) Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
EA200501252A1 (ru) Липосомальная композиция, способ ее получения и лекарственное средство на ее основе (варианты)